background
lack
defin
correl
immun
malaria
combin
inabl
induc
longliv
steril
immun
respons
human
host
demonstr
need
improv
understand
potenti
protect
immun
mechan
enhanc
vaccin
efficaci
protect
steril
immun
plasmodium
falciparum
circumsporozoit
protein
csp
achiev
use
transgen
modifi
plasmodium
berghei
sporozoit
tgpbpfcsp
selfassembl
protein
nanoparticl
sapn
vaccin
present
csp
epitop
pfcspsapn
sever
possibl
mechan
involv
independ
protect
humor
cellular
respons
induc
follow
sapn
immun
describ
method
inbr
mice
vaccin
pfcspsapn
pb
serum
antibodi
harvest
effect
p
falciparum
sporozoit
mobil
integr
examin
use
phase
contrast
microscopi
function
sapninduc
antibodi
inhibit
sporozoit
invas
growth
within
primari
human
hepatocyt
also
examin
intern
process
sapn
bone
marrowderiv
dendrit
cell
bmddc
use
organellespecif
fluorescenttag
antibodi
goldencapsul
sapn
observ
use
confoc
electron
microscopi
respect
result
result
work
demonstr
pfcspsapn
induc
epitopespecif
antibodi
titer
predominantli
isotyp
serum
antibodi
pfcspsapnimmun
mice
appear
target
p
falciparum
sporozoit
via
classic
pathway
complement
result
sporozoit
death
indic
cessat
motil
circumsporozoit
precipit
reaction
moreov
pfcspsapninduc
antibodi
abl
inhibit
wildtyp
p
falciparum
sporozoit
invas
growth
within
cultur
primari
human
hepatocyt
addit
observ
pfcspsapn
process
present
immun
system
dendrit
cell
slow
continu
fashion
via
transport
associ
antigen
process
tap
recruit
earli
endosom
ee
partial
delay
process
endoplasm
reticulum
potenti
induc
longliv
effector
memori
tcell
describ
previous
conclus
paper
describ
examin
humor
cellular
immun
mechan
induc
pfcspsapn
vaccin
result
steril
host
protect
transgen
p
berghei
malaria
sporozoit
express
p
falciparum
csp
significantli
inhibit
nativ
p
falciparum
sporozoit
invad
develop
within
cultur
human
hepatocyt
result
may
indic
type
mode
action
protect
antibodi
need
control
p
falciparum
sporozoit
infect
human
well
potenti
mechan
induct
protect
longliv
effector
memori
tcell
basic
desir
outcom
success
vaccin
induc
steril
longliv
immun
host
histor
vaccin
result
best
achiev
use
chemic
fix
heatkil
liveattenu
organ
case
malaria
approach
rel
unsuccess
interest
recent
dedic
method
recombin
subunit
protein
vaccin
target
variou
parasit
protein
choic
use
combin
immuneboost
adjuv
examin
yield
promis
limit
result
vaccin
rt
current
phase
human
trial
subunit
circumsporozoit
protein
csp
link
hepat
b
surfac
protein
hbsp
selfassembl
nativ
hbsp
form
viruslik
particl
rt
vaccin
result
somewhat
reduc
clinic
infect
longev
studi
examin
observ
reduc
parasit
load
well
detail
investig
possibl
correl
protect
hope
forthcom
next
year
evalu
vaccin
deliveri
platform
malaria
vaccinolog
suffer
lack
understand
viabl
mechan
host
immun
system
abl
effici
respond
highli
polymorph
parasit
even
natur
acquir
immun
slow
develop
easili
lost
littl
evid
support
correl
vaccineinduc
human
plasmodium
immun
steril
protect
vaccin
malaria
could
understand
induc
andor
manipul
effect
mechan
would
lead
complet
protect
longliv
immun
plasmodium
infect
may
better
arm
improv
design
novel
vaccin
platform
could
enhanc
host
immun
end
studi
present
investig
mechan
behind
efficaci
novel
type
immunogen
selfassembl
protein
nanoparticl
sapn
sapn
success
use
deliv
plasmodium
falciparum
cspderiv
tand
bcell
epitop
gener
protect
immun
respons
malaria
believ
act
part
enhanc
repetit
display
highli
immunogen
peptid
innat
immun
system
critic
player
effect
immun
malaria
infect
innat
mechan
protect
first
nonspecif
immun
host
arsen
primari
infect
initi
mechan
link
relat
tailor
respons
requir
properli
effect
protect
secondari
infect
use
poorli
understood
class
adjuv
littl
known
specif
initi
respons
requir
conjunct
vaccin
administr
provid
complet
protect
human
malaria
infect
innat
system
target
synergi
adapt
immun
respons
often
outweigh
immunolog
import
either
isol
variou
vaccin
demonstr
potenti
role
nonspecif
mediat
secret
factor
cell
manag
malaria
infect
may
requir
branch
immun
system
term
understand
promot
crosstalk
branch
achiev
efficaci
vaccin
product
human
malaria
improv
understand
enhanc
awar
potenti
avenu
boost
vaccin
efficaci
paper
examin
sever
interact
innat
adapt
immun
follow
sapn
immun
result
show
sapninduc
antibodi
exhibit
abil
inhibit
motil
induc
complement
c
lysi
malaria
parasit
prior
liver
infect
moreov
track
fluoresc
label
goldtag
sapn
demonstr
delay
process
present
pfcspsapn
dendrit
cell
may
help
explain
induct
previous
report
highli
effect
longliv
adapt
cellular
respons
sapn
synthes
assembl
previous
describ
goldencapsul
sapn
synthes
first
denatur
pfcspsapn
overnight
urea
mm
hepe
ph
mm
nacl
glycerol
next
protein
monom
concentr
mgml
use
amicon
mwco
concentr
monom
dilut
mm
hepe
ph
mm
nacl
glycerol
contain
nm
citrateco
gold
nanoparticl
nanoc
inc
via
thermo
fisher
scientif
inc
pittsburgh
pa
usa
final
molar
ratio
protein
chain
per
gold
nanoparticl
dialysi
perform
overnight
mm
hepe
ph
mm
nacl
glycerol
remov
remain
urea
goldencapsul
sapn
character
transmiss
electron
microscopi
tem
dynam
light
scatter
dl
pfcspsapn
display
nanp
central
repeat
peptid
pfcsp
pfcspkmysapn
also
display
central
repeat
peptid
addit
contain
tcell
epitop
pf
csp
pvcspsapn
contain
scaffold
pf
csp
display
plasmodium
vivax
csp
central
repeat
peptid
femal
mice
five
six
week
age
sexand
agematch
jackson
laboratori
bar
harbor
usa
inject
ip
im
pfcspsapn
steril
salin
total
three
immun
administ
two
week
apart
blood
drawn
antibodi
analysi
one
day
prior
immun
two
week
post
final
immun
via
tail
vein
nick
anim
protocol
conduct
follow
review
approv
wrair
iacuc
serum
antibodi
level
determin
follow
pfcspsapn
immun
elisa
antipfcsp
antibodi
isotyp
profil
determin
use
ige
isotypespecif
goat
antimous
horseradish
peroxidasetag
secondari
antibodi
southern
biotech
birmingham
al
usa
color
chang
initi
abt
peroxidas
solut
kpl
gaithersburg
md
usa
analys
absorb
od
bone
marrow
flush
femur
mice
use
needl
syring
cultur
nine
day
concentr
cellsml
rpmi
complet
media
presenc
ngml
recombin
murin
biovis
mountain
view
ca
usa
ngml
recombin
human
gmcsf
ngml
recombin
human
gmcsf
ngml
recombin
human
peprotech
inc
rocki
hill
nj
usa
well
plate
final
puriti
consist
previou
studi
use
cell
maintain
use
day
nine
ten
cultur
treatedhandl
describ
flow
cytometri
microscopi
surfac
stain
bone
marrowderiv
dendrit
cell
bmddc
perform
evalu
flow
cytometri
antibodi
recogn
antibodi
obtain
bd
bioscienc
san
jose
ca
usa
ebiosci
san
diego
ca
usa
bmddc
harvest
cultur
transfer
eightwel
chamber
slide
allow
adher
overnight
presenc
earli
endosom
ee
marker
invitrogen
eugen
usa
ngml
houselabel
savtap
andor
mmol
lysotrack
invitrogen
eugen
usa
final
stain
volum
cell
also
cocultur
inhous
sapn
ovalbumin
tenminut
twohour
overnight
time
point
slide
wash
fix
methanol
paf
dapi
ad
prior
coverslip
analysi
perform
use
confoc
microscopi
bmddc
cocultur
either
inhous
goldencapsul
sapn
ovalbumin
gold
alon
overnight
harvest
cultur
spun
eight
minut
sapn
ovalbumin
sampl
process
differ
step
forward
sapn
cell
pellet
resuspend
refriger
glutaraldehyd
paraformaldehyd
fix
one
hour
room
temperatur
sampl
postfix
osmium
tetroxid
fortyf
minut
embed
embed
media
mount
copper
grid
ovalbumin
cell
pellet
resuspend
refriger
glutaraldehyd
paraformaldehyd
fix
one
hour
room
temperatur
embed
lr
white
medium
mount
grid
given
secondari
label
antiovalbumin
abcam
cambridg
usa
colloid
goldlabel
insight
genom
fall
church
va
usa
sampl
poststain
uranyl
acet
twenti
minut
lead
citrat
five
minut
room
temperatur
sampl
analys
transmiss
electron
microscopi
jeol
electron
microscop
anophel
stephensi
mosquito
infect
p
falciparum
sporozoit
sacrif
submers
etoh
salivari
gland
dissect
process
use
ozaki
method
sporozoit
isol
sporozoit
place
either
serum
pfcspsapn
immun
anim
pfcspsapn
immun
mous
serum
contain
ethylenediaminetetraacet
acid
edta
chelat
ca
heat
inactiv
pfcspsapn
serum
heat
fortyf
minut
serum
salin
immun
anim
prewarm
roundbottom
plate
twenti
minut
cultur
place
steril
microscop
slide
coverslip
analys
phase
contrast
microscopi
magnif
room
temperatur
immunofluoresc
assay
ifa
slide
process
ad
dilut
serum
sampl
incub
one
hour
wash
three
time
soak
slide
reservoir
pb
wash
secondari
antibodi
fitclabel
goat
antimous
igg
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
ad
dilut
evan
blue
solut
slide
incub
thirti
minut
slide
wash
three
time
pb
describ
previous
allow
air
dri
vectashield
vector
laboratori
inc
burlingam
ca
usa
ad
well
slide
analys
fluoresc
microscop
inhibit
liver
stage
develop
assay
cyropreserv
primari
human
hepatocyt
cphh
cultur
media
plate
triplic
confluenc
onto
collagenco
eightchamb
labtek
slide
incub
overnight
next
day
p
falciparum
sporozoit
collect
salivari
gland
dissect
sporozoit
incub
room
temperatur
twenti
minut
dilut
indic
serum
posit
control
mous
monoclon
antibodi
p
falciparum
repeat
ad
well
contain
cphh
incub
three
hour
allow
sporozoit
infect
cphh
threehour
incub
period
cphh
wash
fresh
cultur
media
remov
noninvad
sporozoit
cphh
harvest
day
upon
harvest
cphh
trypsin
fifteen
minut
wash
twice
fresh
media
hank
balanc
salt
solut
hbss
low
speed
spin
rpm
two
minut
perform
wash
remov
extern
adher
sporozoit
remain
supernat
result
cell
pellet
collect
quantit
realtim
pcr
qrtpcr
use
determin
invasiondevelop
rate
everi
assay
standard
curv
gener
use
known
number
sporozoit
rang
serial
dilut
qrtpcr
data
sampl
compar
standard
curv
quantifi
invasiondevelop
rate
test
sampl
compar
invas
develop
rate
neg
control
c
give
percent
inhibit
pfcspsapninduc
antibodi
predominantli
skew
bind
plasmodium
falciparum
sporozoit
recent
publish
find
found
selfassembl
protein
nanoparticl
contain
peptid
sequenc
nanp
central
repeat
region
circumsporozoit
protein
p
falciparum
induc
antibodi
abl
steril
protect
mice
lethal
challeng
studi
look
immun
respons
human
malaria
p
falciparum
csp
possibl
murin
model
use
transgen
plasmodium
berghei
sporozoit
fulllength
circumsporozoit
protein
csp
gene
replac
p
falciparum
thu
pfcspsapn
induc
antibodi
deriv
mice
specif
csp
protein
human
parasit
p
falciparum
known
stimul
c
undertaken
demonstr
sapninduc
antibodi
particular
isotyp
classic
pathway
c
involv
protect
examin
antibodi
isotyp
profil
deriv
sapnimmun
show
signific
predomin
anticsp
antibodi
figur
demonstr
induct
antibodi
bind
pfcsp
repeat
sequenc
express
genet
modifi
p
berghei
parasit
synthet
amino
acid
sequenc
bound
microtit
plate
import
determin
antibodi
induc
sapn
vaccin
also
bound
csp
nativ
p
falciparum
sporozoit
demonstr
ifa
figur
thu
observ
sapninduc
antibodi
abl
bind
p
falciparum
sporozoit
understand
abl
induc
c
cascad
question
whether
sapninduc
antibodi
would
abl
activ
c
effect
p
falciparum
sporozoit
pfcspsapninduc
antibodi
abl
alter
morpholog
plasmodium
falciparum
sporozoit
prevent
invas
human
hepatocyt
order
examin
potenti
role
antibodyinduc
c
induct
sporozoit
kill
morpholog
p
falciparum
sporozoit
examin
follow
coincub
without
serum
contain
cspspecif
antibodi
deriv
pfcspsapn
immun
within
five
minut
coincub
observ
immun
serum
hamper
halt
sporozoit
motil
phase
contrast
microscopi
demonstr
five
twenti
minut
coincub
obviou
morpholog
chang
parasit
treat
serum
pfcspsapn
immun
mice
control
sera
figur
panel
chang
includ
appear
bleb
bulbou
bulg
apex
parasit
hook
end
phenotyp
elong
thin
parasit
moreov
edta
ad
serum
chelat
calcium
ion
requir
induct
classic
altern
pathway
complement
normal
parasit
phenotyp
maintain
figur
panel
b
indic
specif
classic
pathway
complement
involv
alter
morpholog
appar
destruct
parasit
pfcspsapninduc
anticsp
antibodi
although
suffici
prove
pathway
sole
uniqu
involv
process
strong
indic
import
condit
confirm
without
c
observ
effect
morpholog
absent
heatinactiv
serum
pfcspsapn
immun
anim
coincub
p
falciparum
sporozoit
treatment
alter
sporozoit
phenotyp
observ
figur
panel
c
classic
pathway
c
present
sera
moreov
abl
affect
chang
morpholog
absenc
pfcspsapninduc
antibodi
figur
panel
serum
mice
immun
pvcspsapn
present
p
vivax
csp
repeat
peptid
figur
panel
e
find
collect
indic
pfcspsapn
antibodi
specif
abl
activ
examin
sapninduc
cspspecif
antibodi
abl
inhibit
p
falciparum
parasit
seri
inhibit
liver
stage
develop
assay
ilsda
perform
use
primari
human
hepatocyt
shown
figur
antibodydepend
inhibit
parasit
develop
insid
liver
cell
sporozoit
expos
serum
pfcspsapnimmun
mice
inhibit
observ
use
serum
pvcspsapn
pbssham
immun
mice
test
alon
determin
result
reduct
parasit
develop
insid
liver
cell
due
inhibit
invas
impair
growth
invas
howev
combin
microscop
observ
report
figur
sporozoit
morpholog
chang
presenc
pfcspsapn
immun
sera
strongli
suggest
reduct
parasit
rna
liver
cell
result
fewer
sporozoit
invad
cell
exposur
immun
sera
addit
better
understand
nuanc
humor
respons
deriv
sapn
immun
also
undertaken
understand
way
pfcspsapn
process
present
innat
immun
cell
abl
stimul
previous
observ
highli
effect
longliv
adapt
cellular
respons
analys
vitro
bmddc
microscopi
specif
kinet
sapn
process
bmddc
could
examin
result
confoc
microscopi
show
sapn
delay
process
ee
organel
last
twentyfour
hour
compar
classic
process
refer
protein
ovalbumin
rapidli
process
endoplasm
reticulum
ten
minut
figur
panel
ad
time
consist
crosspres
mechan
sapn
potenti
enhanc
result
cellular
immun
memori
respons
continu
recruit
tap
ee
indic
sapn
highli
local
tap
extend
time
period
organel
membran
would
support
hypothesi
extend
load
sapn
peptid
mhc
class
molecul
figur
panel
sapn
process
lysosom
expect
rate
continu
process
sapn
well
beyond
ova
bmddc
even
twentyfour
hour
figur
panel
c
differenti
delay
process
sapn
confirm
use
transmiss
electron
microscopi
tem
delin
segreg
sapn
particl
within
late
endosomelysosom
fusion
organel
twentyfour
hour
follow
stimul
figur
panel
mere
result
colloid
gold
encapsul
figur
panel
c
furthermor
sapn
particl
demonstr
delay
interact
lysosom
enzym
even
though
major
refer
protein
ova
almost
complet
interact
process
organel
time
point
figur
panel
b
thu
character
abil
sapn
maintain
prolong
process
load
antigen
peptid
onto
mhc
class
molecul
ee
via
recruit
tap
could
ultim
offer
substanti
enhanc
induct
longliv
tlymphocyt
memori
respons
challeng
aspect
design
vaccin
understand
induc
effici
longliv
steril
protect
immun
respons
host
case
malaria
limit
natur
host
immun
observ
endem
area
short
live
person
leav
exposur
area
thu
attempt
mimic
natur
immun
respons
infect
develop
effect
malaria
vaccin
last
quarter
centuri
signific
advanc
limit
overal
success
major
hindranc
work
lack
knowledg
specif
correl
immun
mechan
protect
requir
malaria
infect
novel
way
present
immunogen
protein
epitop
host
immun
system
describ
evid
mechan
action
steril
protect
vaccin
malaria
use
cspderiv
epitop
present
provid
insight
efficaci
evalu
malaria
vaccin
sapncontain
peptid
deriv
sporozoit
cs
protein
predict
stimul
band
tlymphocyt
abl
induc
robust
longliv
respons
p
falciparum
mice
analysi
humor
respons
model
demonstr
antibodi
produc
sapn
immun
predominantli
skew
toward
phenotyp
shown
induc
activ
classic
pathway
complement
cascad
hypothesi
anticsp
antibodi
could
bind
alter
morpholog
sporozoit
first
propos
three
decad
ago
figur
sapn
continu
delay
process
earli
endosom
dendrit
cell
confoc
microscopi
imag
taken
either
ten
minut
panel
b
twentyfour
hour
panel
c
follow
cocultur
bone
marrowderiv
dendrit
cell
either
ovalbumin
panel
c
pfcspsapn
panel
b
red
label
ova
sapn
green
label
ee
tap
lysosom
protein
yellow
result
merg
imag
red
label
ova
sapn
green
organel
marker
dye
blue
dapi
nuclear
stain
repres
imag
shown
six
independ
experi
although
sever
report
observ
socal
circumsporozoit
protein
reaction
circumsporozoit
precipit
reaction
specif
mechan
behind
observ
phenotyp
chang
never
fulli
elucid
observ
incomplet
csp
shed
may
result
natur
antibodi
isotyp
activ
c
specif
fashion
studi
indirectli
demonstr
role
c
use
specif
inhibitor
c
activ
would
import
corrobor
import
classic
pathway
process
c
action
sporozoit
morpholog
function
observ
sapninduc
antibodi
abl
inhibit
sporozoit
motil
may
either
act
conjunct
c
yet
undetect
mechan
independ
c
effect
concert
innat
adapt
immun
respons
potenti
elimin
major
sporozoit
migrat
site
inject
mosquito
liver
potent
action
sapnimmun
serum
antibodi
even
low
titer
indic
antibodi
induc
sapn
abl
affect
shed
csp
target
parasit
destruct
demonstr
high
concentr
antibodi
may
critic
requir
humor
protect
preerythrocyt
malaria
vaccin
scheme
suggest
qualiti
antibodi
import
quantiti
support
observ
ferreira
et
al
shown
antigenspecif
antibodi
abl
neutral
greater
inject
parasit
malaria
infect
model
kaba
et
al
yearlong
studi
demonstr
protect
mice
sporozoit
challeng
sapninduc
pfcspspecif
serum
antibodi
remain
ultim
power
humor
respons
howev
demonstr
abil
pfcspsapn
induc
antibodi
prevent
invas
inhibit
growth
develop
p
falciparum
sporozoit
within
human
hepatocyt
thu
sapn
induc
humor
respons
appear
act
suppress
parasit
motil
induc
activ
classic
pathway
c
sporozoit
lysi
prevent
invas
growth
parasit
cultur
human
liver
hepatocyt
requir
c
absolut
clearli
literatur
demonstr
anticsp
monoclon
antibodi
posit
control
monoclon
use
ilsda
report
work
without
c
must
emphas
select
monoclon
antibodi
includ
c
process
intrigu
observ
howev
even
without
humor
respons
sapninduc
cellular
immun
abl
prevent
bloodstag
malaria
infect
sever
factor
aid
strong
longliv
immun
respons
antigen
variabl
mitogen
dose
exposur
time
affect
robust
result
host
immun
sapn
nm
diamet
allow
easili
pass
lymphat
system
without
need
pick
carri
lymph
node
antigen
present
cell
apc
lymph
node
exogenouslyderiv
nanoparticl
taken
local
predomin
apc
dendrit
cell
dc
process
load
onto
mhc
class
molecul
tlymphocyt
via
process
known
crosspresent
classic
process
sapn
could
account
presenc
univers
pan
helper
epitop
padr
includ
pfcspsapn
vaccin
littl
evid
shown
demonstr
absolut
requir
crosspresent
protein
thing
commonli
agre
import
process
sapn
vaccin
construct
denot
pfcspkmysapn
three
tcell
epitop
peptid
deriv
pfcsp
addit
bcell
target
epitop
pfcsp
repeat
region
use
known
csp
aid
liver
stage
invas
develop
within
host
believ
induct
prime
tcell
respons
liver
result
destruct
parasit
surviv
point
skin
infect
liver
infiltr
mechan
exogenouslydeliv
peptid
present
apc
tcell
antigen
receptor
tlymphocyt
induc
tcell
prime
one
great
enigma
immunolog
crosspresent
goe
dogma
primarili
endogen
deriv
protein
epitop
load
mhc
class
molecul
effici
present
exogen
deriv
antigen
could
induc
would
enabl
highli
effici
robust
respons
multipl
vaccin
scheme
result
enhanc
host
immun
although
nuanc
sapn
function
yet
complet
understood
possibl
order
array
peptid
sequenc
hydrophobichydrophil
natur
andor
physic
structur
intrins
sapn
design
well
dose
antigen
uniqu
effect
enabl
crosspresent
sapn
peptid
immun
system
prolong
segreg
process
sapn
recruit
tap
ee
much
stronger
stimul
extend
period
time
observ
classic
solubl
protein
ovalbumin
observ
give
much
better
understand
mechan
trigger
sapn
induc
refin
longliv
adapt
cellular
immun
respons
observ
follow
sapn
vaccin
light
confoc
tem
result
present
model
crosspresent
process
sapn
within
dc
may
ultim
respons
longliv
band
tcell
respons
observ
follow
sapn
vaccin
put
forward
possibl
explan
sever
propos
model
describ
complex
mechan
behind
crosspresent
promot
observ
delay
segreg
sapn
process
well
recruit
tap
earli
endosom
organel
mechan
crosspresent
taken
sapn
enabl
slow
continu
present
antigen
adapt
immun
system
compar
tradit
model
direct
shuttl
cytoplasm
peptid
endoplasm
reticulum
load
onto
mhc
class
molecul
model
peptid
process
promot
induct
longliv
cellular
respons
vaccinedeliv
peptid
process
sapn
appear
occur
lysosomeendoplasm
reticulum
stage
follow
accept
model
tcellpredict
peptid
process
present
via
mhc
class
ii
molecul
classic
manner
thu
evid
present
support
mechan
crosspresent
result
presenc
longliv
memori
tlymphocyt
demonstr
previous
previou
work
examin
proven
sapn
platform
viabl
method
induc
longliv
effect
adapt
host
immun
respons
mice
via
deliveri
process
parasit
antigen
potenti
improv
vaccin
could
made
addit
adjuv
order
boost
magnitud
respons
need
higher
order
mammal
also
inclus
sequenc
malaria
strain
p
vivax
csp
repeat
sequenc
epitop
variou
p
falciparum
protein
encompass
sever
parasit
life
stage
singl
platform
could
enhanc
scope
immun
